Home › NDC Lookup › Ingredients › Tetrahydrozoline Hcl 0.05% › 24385-0075-05
👁️image loading
(from DailyMed)

Good Neighbor Pharmacy Eye Drops Original Formula Tetrahydrozoline HCl 0.05% .05 g/100mL Solution/ Drops — NDC 24385-075-05 (Billing 24385-0075-05)

by AmerisourceBergen Drug Corporation · 1 BOTTLE, DROPPER in 1 CARTON / 15 mL in 1 BOTTLE, DROPPER

This is a package of Good Neighbor Pharmacy Eye Drops Original Formula Tetrahydrozoline HCl 0.05% .05 g/100mL Solution/ Drops from AmerisourceBergen Drug Corporation, no longer marketed (first marketed Jan 2001), no longer in the FDA NDC Directory, this package's marketing ended Jul 2026; retail pharmacies pay about $0.0969 per mL (NADAC). It is this product's only package size.

NDC 24385-0075-05
🏷️ FDA NDC (as labeled) 24385-075-05 billing pads the product segment with a zero
OTC Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 2, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 24385-075-05 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
24385 labeler · 075 product · 05 package
Package marketed since
Jan 29, 2001
Package marketing ended
Jul 3, 2026
Sample package
No — commercial package
Barcode (UPC)
0087701149757
Medicaid fills, this package
13 prescriptions in the last four reported quarters
FDA record last changed
Jul 2, 2026
🚨
Active recall for this product.
Class II · Mar 3, 2026 — Lack of Assurance of Sterility (K.C. Pharmaceuticals, Inc) · FDA recall D-0413-2026
Lots / codes: Lot: a) RG24E01, Exp.: 05/31/26; RG24G02, Exp.: 07/31/26; b) RG24E01, Exp.: 05/31/26; RG24G02, Exp.: 07/31/26; c) RG24G02, Exp.: 07/31/26; d) RG24E01, Exp.: 05/31/26; RG24G01, RG24G02; Exp.: 07/31/26; e) RG24E01, Exp.: 05/31/26; RG24G01, Exp.: 07/31/26; f) RG24E01, Exp.: 05/31/26; RG24G02; Exp.: 07/31/26; g) RG24E01, Exp.: 05/31/26; h) RG24E01, Exp.: 05/31/… · reported Apr 8, 2026
Class II · Jun 13, 2023 — CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line. (K.C. Pharmaceuticals, Inc) · FDA recall D-0897-2023
Lots / codes: Lot #: a) RG21F01, Exp: 6/30/2023; b) RG21F01, Exp: 6/30/2023; c) RG21F01, Exp: 6/30/2023; d) RG21F01, RG21F02, Exp 6/30/2023; e) RG21F02, RG21F03, Exp 6/30/2023; f) RG21F02, Exp 6/30/2023; g) RG21F02, Exp 6/30/2023; h) RG21F02, Exp 6/30/2023; i) RG21F02, Exp 6/30/2023; j) RG21F02, Exp 6/30/2023; k) RG21F02, Exp 6/30/2023; l) RG21F02, Exp 6/30/2023; m) RG21… · reported Jul 19, 2023
Check your lot/expiration against the official notice — look up the recall number in the FDA recall database ↗
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Jul 2026. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 24385-075-05
Product NDC 24385-075
11-digit billing NDC 24385007505
NCPDP billing unit ML — per mL (volume)
RxCUI 1052943
UNII 0YZT43HS7D
UPC 0087701149757
Application # M018
SPL Set ID 1e39e3a5-34fe-4e73-8f5c-219c4ef31bfb
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Jul 2026)
Marketing start 2001-01-29
Marketing end 2026-07-03
Route OPHTHALMIC
Dosage form SOLUTION/ DROPS
Substance TETRAHYDROZOLINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 86400050102005
GPI class GNP Eye Drops
GCN Seq No 007771
GCN 32311
HICL code 015909
Ingredient (HICL) Tetrahydrozoline Hcl
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q6
Therapeutic class — intermediate (HIC2) Ophthalmic Preparations
HIC3 code Q6D
Therapeutic class — specific (HIC3) Eye Vasoconstrictors (Otc Only)
AHFS code 52:32.00.00
AHFS class Vasoconstrictors
FDB label name EYE DROPS
FDB brand name Eye Drops
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 007771
  • GCN: 32311
  • GPI-14 (Medi-Span): 86400050102005
  • HICL (First Databank): 015909
  • AHFS class code: 52:32.00.00
  • RxCUI (RxNorm): 1052943
Why two NDCs? The FDA registers this code as 24385-075-05 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 24385-0075-05. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Sympathomimetics, plain class.

Drug family (ATC) Sympathomimetics, plain, Sympathomimetics used as decongestants
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name EYE DROPS Ingredient Tetrahydrozoline Hcl
📖 What it is MedlinePlus · NLM

Ophthalmic tetrahydrozoline is used to relieve minor eye irritation and redness caused by colds, pollen, and swimming.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It relieves the redness you see, but it doesn't treat the underlying cause of the irritation. Think of it as a short-term fix to take the red out. If something is genuinely botheri...
  • What exactly does this eye drop do — does it actually fix what's irritating my eye?
  • No — you should remove your contact lenses before putting in the drops. The solution can be absorbed by soft contacts, which can affect the lens and potentially irritate your eye....
  • Can I wear my contact lenses while using these drops?
📖 Read our full Tetrahydrozoline Ophthalmic guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.097 $1.45 / 15 ml
Medicaid paysCMS SDUD · 12 mo $0.4577 $6.87 / 15 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2021 May 2022 Nov 2022 Feb 2026 $0.122 $0.095
▲ Up 2% over the last 16 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
24385-0075-05 You're viewing this Main listing 1 BOTTLE, DROPPER in 1 CARTON / 15 mL in 1 BOTTLE, DROPPER 2001-01-29 Jul 3, 2026 Discontinued by firm

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Neighbor Pharmacy Eye Drops Original Formula .05 g/100mLthis 24385-0075-05 AmerisourceBergen 1 bottle $0.097 — Discontinued —
Foster and Thrive Original Formula Eye Drops .05 g/100mL 70677-1159-01 Strategic 1 bottle $0.097 — Availability likely —
Quality Choice Eye Drops Redness Relief .05 g/100mL 83324-0340-15 Chain 1 bottle $0.097 — Availability likely —
Sunmark Eye Drops Original Formula .05 g/100mL 49348-0037-29 Strategic 1 bottle $0.115 — FDA listed +19%
Walgreens Eye Drops Original 15mL and twin pack .05 g/100mL 00363-4550-01 Walgreens 1 bottle — — FDA listed —
Kroger Eye Drops Original .05 g/100mL 30142-0574-01 The 1 bottle — — FDA listed —
TopCare Health Original Eye Drops .05 g/100mL 36800-0858-01 Topco 1 bottle — — FDA listed —
HEB Original Eye Drops .05 g/100mL 37808-0577-01 HEB 1 bottle — — FDA listed —
Meijer Redness Relief .05 g/100mL 41250-0814-01 Meijer 1 bottle — — FDA listed —
GoodSense Eye Drops Original Formula .05 g/100mL 50804-0141-01 Geiss, 1 bottle — — FDA listed —
CAREALL Eyedrops Original .5 mg/mL 51824-0039-05 New 15 ml — — Discontinued —
Discount Drug Mart Eye Drops Original .05 g/100mL 53943-0073-01 Discount 1 bottle — — FDA listed —
Family Wellness Original Redness Relief Eye Drops .05 g/100mL 55319-0907-01 Family 1 bottle — — FDA listed —
Medics Choice Eye Drops Original Redness Reliever .5 mg/mL 55651-0005-01 KC 1 bottle — — FDA listed —
Original Redness Reliever .05 g/100mL 55651-0063-01 KC 1 bottle — — FDA listed —
DG Original Eye Drops .05 g/100mL 55910-0363-01 Dolgencorp 1 bottle — — FDA listed —
CVP Sterile Eye Drops .05 g/100mL 57243-0068-01 Salado 1 bottle — — FDA listed —
Preferred Plus Pharmacy Redness Relief Eye Drops .05 g/100mL 61715-0212-01 Kinray 1 bottle — — FDA listed —
Best Choice Eye Drops Original .05 g/100mL 63941-0139-01 Valu 1 bottle — — FDA listed —
Redness Reliever, Circle K .5 mg/mL 66715-5429-04 Lil' 1 bottle — — FDA listed —
Lil Drug Store Eye Drops Redness Reliever .5 mg/mL 66715-6832-04 Lil 1 bottle — — FDA listed —
CIRCLE K sterile eye drops .05 g/100mL 66715-8882-01 Lil' 1 bottle — — FDA listed —
Lil Drug Store Sterile Eye Drops Redness Reliever .05 g/100mL 66715-8883-01 Lil' 1 bottle — — FDA listed —
Winco Original Formula Eye Drops .05 g/100mL 67091-0310-15 WinCo 1 bottle — — FDA listed —
Equate Eye Drops .5 mg/mL 67172-0281-01 Prestige 1 bottle — — Discontinued —
Equate Eye Drops .5 mg/mL 67172-0282-01 Prestige 1 bottle — — Discontinued —
Harris Teeter Eye Drops Original .05 g/100mL 69256-0977-01 Harris 1 bottle — — FDA listed —
Visine Red Eye Comfort .5 mg/mL 69968-0355-01 Kenvue 1 bottle — — FDA listed —
Equate Original Eye Drops .05 g/100mL 79903-0158-05 Walmart, 1 bottle — — FDA listed —
Original Redness Reliever .05 g/100mL 79903-0363-01 Walmart 1 bottle — — FDA listed —
Equaline Sterile Eye Drops .05 g/100mL 83455-0210-01 United 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2001
On the market since
Jan 2001
📍
2026
Currently FDA-listed
25 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAmerisourceBergen Drug Corporation
FDA applicationM018 (OTC MONOGRAPH DRUG)
Labeler code24385
First marketedJan 2001
Product typeHuman Otc Drug
Portfolio37 products on file

More NDCs from AmerisourceBergen Drug Corporation labeler code 24385

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 11 words ▾

Uses relieves redness of the eye due to minor eye irritations

⏱️ Dosage and Administration 15 words ▾

Directions Instill 1 or 2 drops in the affected eye(s) up to four times daily.

⚠️ Warnings 126 words ▾

Warnings For external use only Ask a doctor before use if you have narrow angle glaucoma When using this product pupils may become enlarged temporarily to avoid contamination, do not touch tip of container to any surface. Replace cap after using. if solution changes color or becomes cloudy, do not use overuse may produce increased redness of the eye remove contact lens before using Stop use and ask a doctor if you experience eye pain changes in vision continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 5 words ▾

Active Ingredient Tetrahydrozoline HCl 0.05%

🧪 Inactive Ingredients 15 words ▾

Inactive ingredients benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate, and sodium chloride

🎯 Purpose 3 words ▾

Purpose Redness reliever

📄 Ask a Doctor Before Use If 11 words ▾

Ask a doctor before use if you have narrow angle glaucoma

📄 When Using This Product 48 words ▾

When using this product pupils may become enlarged temporarily to avoid contamination, do not touch tip of container to any surface. Replace cap after using. if solution changes color or becomes cloudy, do not use overuse may produce increased redness of the eye remove contact lens before using

📄 Stop Use and Ask a Doctor If 33 words ▾

Stop use and ask a doctor if you experience eye pain changes in vision continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 7 words ▾

Other information Store at 15 °-30°C (59°-86°F)

📄 Package Label / Principal Display Panel 6 words ▾

Good Neighbor Pharmacy Eye Drops 24385007505.jpg

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
13
Units reimbursed last 4 qtrs
115
Gross reimbursed last 4 qtrs
$52.63
Avg / prescription
$4.05
Avg / unit
$0.4577
Latest quarter Q1 2026
0Rx
Medicaid pays / mL
$0.4577
gross reimbursed
vs
NADAC / mL
$0.0969
acquisition cost
=
Spread
+$0.3608
+372% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
100% MCO
Fee-for-service · 0 Rx Managed care · 13 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: 115 units · 1.2 per 100k residents NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
1.21.2
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New Jersey 1.2 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) ✓ Available
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
AmerisourceBergen Drug Corporation is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 24385-0072-82 · Amerisource 24385-0106-80 · AmerisourceBergen →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.